Simplex Trading
KZIA

Simplex Trading’s Kazia Therapeutics KZIA Stock Holding History

Simplex Trading’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.44K Buy
+1,000
New +$6.96K ﹤0.01% 7606
2025
Q1 		– Sell
-1,160
Closed -$10K – 9107
2024
Q4 		$10K Buy
+1,160
New +$26.8K ﹤0.01% 7194
2022
Q2 		– Sell
-6
Closed -$2K – 10554
2022
Q1 		$2K Sell
6
-4
-40% -$1.43K ﹤0.01% 9871
2021
Q4 		$4K Buy
+10
New +$4.99K ﹤0.01% 9685
2021
Q2 		– Hold
0
– -$14K – 10387
2021
Q1 		– Hold
0
– – – 7702

Other funds holding KZIA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Simplex Trading's KZIA Position: Q2 2025 in Review

Simplex Trading sold out of Kazia Therapeutics (KZIA) in Q2 2025, closing a stake of 1 share.

Simplex Trading first reported a position in KZIA in Q4 2020 and held it in 10 quarters. The position peaked at $63K in Q4 2021. 10 funds tracked by Wall St. Rank hold KZIA as of Q2 2025.

  • Simplex Trading reported no remaining Kazia Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 1 Kazia Therapeutics share in Q2 2025.
  • Simplex Trading first reported a position in Kazia Therapeutics in Q4 2020 and held it in 10 quarters.
  • Simplex Trading's Kazia Therapeutics position peaked at $63K in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.